E-LIB Suche - Ergebnisse für: Joffe, E.

1

OC-0092 Patient Selection Using Genetic Alterations Associa..:

Wijetunga, N.A. ; Lebow, E. ; Lee, J....
Radiotherapy and Oncology. 182 (2023) - p. S55 , 2023

Link: https://doi.org/10.1016/..

2

A single‐center experience of low‐dose radiotherapy for pri..:

Freret, M. E. ; Tringale, K. R. ; Imber, B. S....
Hematological Oncology. 41 (2023) S2 - p. 393-394 , 2023

Link: https://doi.org/10.1002/..

3

Genetic Alterations in Follicular Lymphoma Predict Response..:

Wijetunga, N. A. ; Lebow, E. ; Chan, A....
Hematological Oncology. 41 (2023) S2 - p. 291-292 , 2023

Link: https://doi.org/10.1002/..

4

Genomic Correlates of Radiosensitivity in Diffuse Large B C..:

Sarkar, R. R. ; Ma, J. ; Wijetunga, N. A....
Hematological Oncology. 41 (2023) S2 - p. 304-305 , 2023

Link: https://doi.org/10.1002/..

5

PO-1170 Low-dose radiotherapy for extranodal marginal zone ..:

Freret, M. ; Imber, B. ; Joffe, E...
Radiotherapy and Oncology. 170 (2022) - p. S991-S992 , 2022

Link: https://doi.org/10.1016/..

6

PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RE..:

Nowakowski, G. S. ; Yoon, D. H. ; Joffe, E....
HemaSphere. 6 (2022) - p. 1982-1983 , 2022

Link: https://doi.org/10.1097/..

7

CO67 Tafasitamab Plus Lenalidomide (TAFA+LEN) Versus Pola-B..:

Córdoba, R ; Zinzani, PL ; Joffe, E...
Value in Health. 25 (2022) 12 - p. S30 , 2022

Link: https://doi.org/10.1016/..

8

P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND..:

Joffe, E. ; Nowakowski, G. ; Tun, H....
HemaSphere. 6 (2022) - p. 1011-1012 , 2022

Link: https://doi.org/10.1097/..

9

Rapallo und die friedliche Koexistenz

Schriften der Deutschen Sektion der Kommission der Historiker der DDR und der UdSSR ; 3

Anderle, Alfred ; Anderle, Alfred ; Besymenski, L. A... - Reprint 2021 . , [2021]

Link: https://doi.org/10.1515/..

10

CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAG..:

Sha, F. ; Okwali, M. ; Alperovich, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

11

AN OPEN‐LABEL TRIAL OF ORAL CA‐4948 AN IRAK4 INHIBITOR COMB..:

Joffe, E. ; Ramchandren, R. ; Nowakowski, G....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

12

Predictors of Response to Very Low Dose Radiotherapy (4Gy) ..:

Imber, B.S. ; Chau, K.W. ; Lee, J....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. S106 , 2021

Link: https://doi.org/10.1016/..

13

GRADE 3A FOLLICULAR LYMPHOMA CAN BE EFFECTIVELY CONTROLLED ..:

Imber, B.S. ; Chau, K. ; Goldberg, E...
Hematological Oncology. 37 (2019) S2 - p. 391-392 , 2019

Link: https://doi.org/10.1002/..

14

INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORM..:

Rajeeve, S. ; Bobillo, S.V. ; Zelenetz, A.D....
Hematological Oncology. 37 (2019) S2 - p. 264-266 , 2019

Link: https://doi.org/10.1002/..

15

Radiotherapy is an Effective Definitive Treatment for Limit..:

Goldberg, E. ; Imber, B.S. ; Chau, K...
International Journal of Radiation Oncology*Biology*Physics. 103 (2019) 4 - p. 1016-1017 , 2019

Link: https://doi.org/10.1016/..